MedPath

Ear Drops for Children With Otitis Media

Not Applicable
Completed
Conditions
Acute Otitis Media
Interventions
Drug: Hyland's earache drops
Registration Number
NCT00622518
Lead Sponsor
University of Washington
Brief Summary

The purpose of this study is to determine if a commercially available homeopathic ear drop preparation is effective in reducing symptoms in children 6 months - 11 years old with acute otitis media. A total of 120 study patients with otitis media will be randomized to receive homeopathic ear drops, or no ear drops, in addition to receiving standard care. It is postulated that children using the ear drops will have more rapid resolution of symptoms and need fewer antibiotics than those randomized to not receive the ear drops.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
119
Inclusion Criteria
  • Presenting to participating clinic with otitis media
  • Diagnosed with acute otitis media
  • Parents rate symptoms as a "moderate problem" or more
Read More
Exclusion Criteria
  • Diagnosis of otitis media within preceding 30 days
  • Receipt of antibiotics within 2 days
  • Perforated ear drum or bullous lesion
  • Receipt of homeopathic treatment within 30 days
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Hyland's earache dropshomeopathic ear drops in addition to standard care for otitis media
Primary Outcome Measures
NameTimeMethod
Resolution of Otitis Media Symptoms5 days

Mean scores as measured on the Ear Treatment Group-5 scale. This scale quantifies severity of symptoms in children with otitis media. There are 5 components to the scale: fever, earache or tugging, feeding, irritability and sleep. For each component symptoms are rated as 0, 4 or 7 based on severity, with higher scores indicating more sever symptoms. For the primary outcome, the scores for each component were summed to determine an overall Ear Treatment Group -5 Scale score. Total scores range from 0-35. Two assessessments were conducted each day.

Secondary Outcome Measures
NameTimeMethod
Side Effects of Therapy5 days

Trial Locations

Locations (1)

University of Washington Medical Center-Roosevelt Pediatric Care Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath